期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

免疫评分的研究进展

Research progress of immunoscore
原文传递
导出
摘要 学者们在关注肿瘤组织免疫特性的基础上提出了一种名为“免疫评分”的肿瘤预测预后新方法，已被证明是一种优于国际抗癌联盟-美国癌症联合委员会（UICC-AJCC）TNM分期的预后因素，近年来已有其应用于结直肠癌等肿瘤的相关报道。该方法操作简单，花费低，且准确性高，可用于指导个体化治疗，但要成为临床常规检测指标仍有其局限性。 A methodology named ＆quot;immunoscore＆quot;has been proposed in recent years.It has been demonstrated to be a prognostic factor superior to the Union for International Cancer Control-American Joint Committee on Cancer （UICC-AJCC）TNMclassification.Over the past few years,it has gained a forefront posi-tion in colorectal cancer.It has the advantages of simple operation,low cost and high accuracy,and it is nee-ded for individual therapy.However,it still has its limitations.
作者 赵新茹 赵玉叶 李国洪 阚璇 牛作兴
机构地区 济南大学山东省医学科学院医学与生命科学学院 山东省邹城市中医院肛肠科 山东省枣庄市峄城区中医院肿瘤科 山东省肿瘤医院内科
出处 《国际肿瘤学杂志》 CAS 2016年第10期772-774,共3页 Journal of International Oncology
关键词 肿瘤分期 预后 免疫评分 Neoplasm staging Prognosis Immunoscore
分类号 R730.3 [医药卫生—肿瘤]
  • 相关文献

参考文献20

  • 1Mlecnik B, Tosolini M, Kirilovsky A, et al. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction[J]. J Clin Oncol, 2011, 29(6) : 610- 618. DOI: 10. 1200/JCO. 2010.30. 5425.
  • 2孙成,田志刚.免疫评分:依据肿瘤组织免疫特性进行预后预测[J].中国肿瘤生物治疗杂志,2015,22(2):177-182. 被引量：5
  • 3Mlecnik B, Bindea G, Pages F, et al. Tumor immunosurveillance in human cancers[J]. Cancer Metastasis Rev, 2011, 30( 1 ) : 5-12. DOI : 10. 1007/s10555-011-9270-7.
  • 4Nagtegaal ID, Quirke P, Schmoll HJ. Has the new TNM classification for colorectal cancer improved care? [ J]. Nat Rev Clin Oncol, 2012, 9(2) : 119-123. DOI: 10. 1038/nrclinonc. 2011. 157.
  • 5Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation [J]. Cell, 2011, 144(5) : 646-674. DOI: 10. 1016/j. cell 2011. 02. 013.
  • 6Zlobec I, Bihl M, Foerster A, et al. Comprehensive analysis of CpG island methylator phenotype (CIMP) -high, -low, and -negative colo- rectal cancers based on protein marker expression and molecular fea- tures[J]. J Pathol, 2011,225(3) : 336-343. DOI: 10. 1002/path. 2879.
  • 7Laghi L, Malesci A. Microsatellite instability and therapeutic conse- quences in colorectal cancer[J]. Dig Dis, 2012, 30(3) : 304-309. DOh 10.1159/000337003.
  • 8Galon J, Mlecnik B, Bindea G, et al. Towards the introduction of the 'immunoscore' in the classification of malignant tumours [ J]. J Pathol, 2014, 232(2) : 199-209. DOI: 10. 1002/path. 4287.
  • 9Ingels A, Sanchez Salas RE, Ravery V, et al. T-helper 1 immunore- action influences survival in muscle-invasive bladder cancer: proof of concept[ J]. Ecancermedicalscience, 2014, 8.. 486. DOI: 10. 3332/ecancer. 2014. 486.
  • 10Van Den Boom JG, Hartmann G. Turning tumors into vaccines : co- opting the innate immune system[ J]. Immunity, 2013, 39 (1) : 27- 37. DOI : 10. 1016/j. immuni. 2013.07.011.

二级参考文献53

  • 1Gao Q,Qiu SJ,Fan J,Zhou J,Wang XY,Xiao YS,et al.Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. Journal of Clinical Oncology . 2007
  • 2Verhaak, Roel G W,Tamayo, Pablo,Yang, Ji-Yeon,Hubbard, Diana,Zhang, Hailei,Creighton, Chad J,Fereday, Sian,Lawrence, Michael,Carter, Scott L,Mermel, Craig H,Kostic, Aleksandar D,Etemadmoghadam, Dariush,Saksena, Gordon,Cibulskis, Kristian,Duraisamy, Sekhar,Levanon, Keren,Sougnez, Carrie,Tsherniak, Aviad,Gomez, Sebastian,Onofrio, Robert,Gabriel, Stacey,Chin, Lynda,Zhang, Nianxiang,Spellman, Paul T,Zhang, Yiqun,Akbani, Rehan,Hoadley, Katherine A,Kahn, Ari,K?bel, Martin,Huntsman, Da.Prognostically relevant gene signatures of high-grade serous ovarian carcinoma[J]. Journal of Clinical Investigation . 2013 (1)
  • 3Coley WB. Contribution to the Knowledge of Sarcoma[ J]. Ann Surg, 1891,14:199 -220.
  • 4Huppa JB, Davis MM. T - cell - antigen recognition and the immu- nological synapse[J]. Nat Rev lmmunol,2003, 3:973 -983.
  • 5Leach DR, Krummel MF, Allison JP. Enhancement of antitumor im- munity by CTLA-4 blockade[J]. Sc/ence,1996,271:1734 -1736.
  • 6Blankenstein T, Coulie PG, Gilboa E, et al. The determinants of tumour immunogennicity [ J]. Nat Rev Cancer, 2012, 12:307 -313.
  • 7Hobeika AC, Morse MA, Osada T,et ol. Enumerating antigen -spe- cific T- cell ,responses in peripheral blood: a comparison of peptide MHC Tetramer, ELISpot and intracellular cytokine analysis [J]. lm- munother, 2005,28:63-72.
  • 8Walker EB, Disis ML. Monitoring immune responses in cancer pa- tients receiving tumor vaccines [ J ]. Int Rev lmmunol, 2003, 22:283 -319.
  • 9Janetzki S, Britten CM, Kalos M, et al. ' MIATA' - minimal infor- mation about T cell assays [J]. Immunity, 2009,31 : 527 -528.
  • 10Britten CM, Gouttefangeas C, Welters MJ,et al. The CIMT -monito- ring panel : a two - step approach to harmonize the enumeration of an- tigen - specific CD8 + T lymphocytes by structural and functional as- says [ J ]. Cancer Irrmmnol Immunother,2008,57 : 289 - 302.

共引文献5

国际肿瘤学杂志
2016年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部